Controversial Killer Flu Research Paused | Wired Science | Wired.com
Researchers developing extra-contagious strains of H5N1 avian influenza have agreed to pause their work for 60 days.
The moratorium, announced Jan. 20 in Nature and Science, is a response to public fear and alarm in the scientific community, which has split over whether the research could inadvertently lead to release of a nightmare disease.
Critics, including many high-profile virologists, epidemiologists and biosecurity experts, said it was possible that would-be biological terrorists could use the research to develop weaponized flu strains. Another, perhaps more frightening possibility was unintentional release: dozens of accidental infections (.pdf) have occurred at high-security laboratories in the United States, and it’s thought that one now-global flu strain may actually have escaped from a Russian laboratory in the 1970s. Against these risks, the benefits were arguable, and some virologists even said that mutations engineered in a laboratory didn’t necessarily illuminate future dangers.
“The research should never have been undertaken because the potential harm is so catastrophic and the potential benefits from studying the virus so speculative,” opined the New York Times in a Jan. 8 editorial entitled “An Engineered Doomsday.”
Contrary to the researchers’ insistence that the work was “using the highest international standards of biosafety and biosecurity,” it was conducted at so-called Biosafety Level 3 — a set of techniques and safeguards less strict than is used for Ebola and the Marburg virus, which pose less potential threat than an H5N1 strain that easily infects people.